OTC:RAJAF | Profit Breakdown | TFA Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-12-31 to 2025-12-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2023-12-31$315,502.00$284,660.00$120,448.00$83,430.00$901,171.00
2022-12-31-$36,901.00-$36,891.00-$77,046.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$1.25M$760,741.00-$141,128.00-$154,822.00-$154,822.00
2024-12-31$1.25M$906,480.00-$183,913.00-$191,301.00-$226,258.00
2023-12-31$882,533.00$766,387.00$227,833.00$190,815.00$751,609.00
2022-12-31$53,304.00$39,558.00-$415,121.00-$415,111.00-$720,093.00
2021-12-31$879,318.00-$176,212.00-$119,387.00-$119,380.00-$491,006.00